Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...
Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...
Balancing safety and convenience, innovative stick pack designs offer a patient-centric solution for on-the-go dosage forms.
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.
Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...
Navigating compliance challenges and technology solutions under DSCSA.
National Resilience Inc., a technology-focused biomanufacturing company, is initiating the next phase of its growth in the ...
The FDA has cleared Everest Medicines’ Investigational New Drug (IND) application for EVM14, a Tumor-Associated Antigen (TAA) ...
BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.
Singota Solutions has opened a new facility in Balerna, Switzerland, offering a location touching extensive European ...
How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.